Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008

Journal of Medical Virology

Volumn 82, Issue 7, 2010, Pages 1291-1294

  Stańczak, Grzegorz P ^a   Stańczak, Janusz J ^a   Marczyńska, Magdalena ^b   Firla̧g Burkacka, Ewa ^a   Wiercińska Drapało, Alicja ^b   Leszczyszyn Pynka, Magdalena ^c   Jabłonowska, Elzbieta ^d   Małolepsza, Ewa ^d   Dyda, Tomasz ^a   Za̧bek, Piotr ^a   Horban, Andrzej ^a,b  

^a SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Drug resistance; HIV 1; Poland; Subtypes

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEIN INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLAND; SEXUAL TRANSMISSION; ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; CHILD; CLASSIFICATION; DRUG EFFECTS; GENETICS; HIV INFECTIONS; INFANT; MIDDLE AGED; MUTATION; NEWBORN; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION; POLAND; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; YOUNG ADULT;

EID: 77954406970     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21782     Document Type: Article

References (12)

1. Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD, EuroSIDA Study Group. 2008. Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study. J Acquir Immune Defic Syndr 48:324-333.
2. de Mendoza C, del Romero J, Rodríguez C, Corral A, Soriano V. 2007. Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Spain. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, Poster No. 371-M.
3. Guillot V, Perez Cachafeiro S, Caro AM, Moreno S, Del Romero J, Soriano V, Gómez JL, Pineda JA, Dalmau D, De Mendoza C, García F, CoRIS. 2009. High prevalence of HIV non-B subtypes and primary drug resistance in the cohort of the Spanish AIDS Research Network (CoRIS). 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, Poster No. WEPEB201.
4. Horban A, Stanłczak JJ, Ba?kowska E, Tobolewska EJ, Przybylska-Stengiel KJ, Stanłczak GP, Burkacka E. 2002. High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort. Infection 30:356-359.
5. Hughes GJ, Fearnhill E, Dunn D, Lycett SJ, Rambaut A, Leigh Brown AJ. 2009. UK HIV Drug Resistance Collaboration. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 5:e1000590. Epub 2009 Sep 25.
6. Leszczyszyn-Pynka M, Parczewski M, Bander D. 2009. Transmission of NNRTI resistance diagnosed during acute HIV infection. HIV & AIDS Rev (in press).
7. Payne BA, Nsutebu EF, Hunter ER, Olarinde O, Collini P, Dunbar JA, Basta MS, Elston JW, Schmid ML, Thaker H, Chadwick DR. 2008. Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort. J Antimicrob Chemother 62:464-468.
8. Stańczak GP, Stańczak JJ, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynka M, Jabłonowska E, Małolepsza E, Horban A. 2007a. Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland. Przegl Epidemiol 61:29-34.
9. Stańczak GP, Stańczak JJ, Pulik P, Firla̧g-Burkacka E, Przybylska-Stengiel KJ, Dyda TM, Za̧bek P, Horban A. 2007b. Significant changes in the prevalence of HIV-1 drug resistant mutants and HIV-1 subtypes in Polish population. 11th European AIDS Conference (EACS) 25-28 October 2007, Madrid, Spain.
10. The SPREAD Programme. 2008.Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 22:625-635.
11. UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study, UK Register of HIV Seroconverters. 2007. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS 21:1035-1039.
12. Wensing A. 2009. Transmission of drug resistance in Europe. 4th International Workshop on HIV Transmission, Cape Town. Oral Presentation.